Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease

被引:44
作者
Schuetz P. [1 ]
Christ-Crain M. [1 ]
Schild U. [1 ]
Süess E. [1 ]
Facompre M. [2 ]
Baty F. [2 ]
Nusbaumer C. [3 ]
Brutsche M. [2 ]
Müller B. [1 ]
机构
[1] Division of Endocrinology, Diabetes and clinical Nutrition, University Hospital Basel, CH-4031 Basel
[2] Division of Pneumology, Department of Chemical Pathology, University Hospital Basel, CH-4031 Basel
[3] Department of Internal Medicine, University Hospital Basel, CH-4031 Basel
关键词
Chronic Obstructive Pulmonary Disease; Cortisol; Adrenal Insufficiency; Systemic Corticosteroid; Basal Cortisol;
D O I
10.1186/1471-2466-8-1
中图分类号
学科分类号
摘要
Background: As supra-physiological intake of corticosteroids is a well known risk factor for the development of adrenal insufficiency, we investigated the function of the hypothalamic-pituitary-adrenal (HPA) axis during a 14-day course of systemic corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary disease using clinical and laboratory measures. Methods: A systematic clinical and laboratory assessment including measurement of basal cortisol levels and the response to low dose (1 μg) ACTH stimulation was performed in nine patients before, on the first and the last day of treatment, as well as 2, 7 and 21 days after corticosteroid withdrawal. Results: At baseline, all nine patients had normal responses to 1 μg ACTH. On the first day of steroid treatment, 78% had a blunted peak cortisol response. This percentage increased to 89% after 14 days of steroid treatment. 78%, 33% and 33% of the patients had a blunted cortisol response to ACTH 2, 7, and 21 days after corticosteroid withdrawal, respectively. ROC curve analysis revealed that only basal cortisol concentrations (AUC 0.89), but not ACTH concentrations (AUC 0.49) or clinical signs (AUC 0.47) were predictive of an impaired function of the HPA axis. Basal cortisol levels of > 400 and < 150 nmol/l were 96% and 100% sensitive for a normal or pathological response to the ACTH stimulation test, respectively. Conclusion: Immediate and prolonged suppression of the HPA axis is a common finding in otherwise asymptomatic patients undergoing systemic steroid treatment for acute exacerbation of chronic obstructive pulmonary disease and can reliably be assessed with the low-dose ACTH test. © 2008 Schuetz et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 21 条
[1]  
Niewoehner D.E., Erbland M.L., Deupree R.H., Collins D., Gross N.J., Light R.W., Anderson P., Morgan N.A., Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease, N Engl J Med, 340, pp. 1941-1947, (1999)
[2]  
Niewoehner D.E., The role of systemic corticosteroids in acute exacerbation of chronic obstructive pulmonary disease, Am J Respir Med, 1, pp. 243-248, (2002)
[3]  
Cooper M.S., Stewart P.M., Corticosteroid insufficiency in acutely ill patients, N Engl J Med, 348, pp. 727-734, (2003)
[4]  
Henzen C., Suter A., Lerch E., Urbinelli R., Schorno X.H., Briner V.A., Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment, Lancet, 355, pp. 542-545, (2000)
[5]  
Rasmuson S., Olsson T., Hagg E., A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis, Clin Endocrinol (Oxf), 44, pp. 151-156, (1996)
[6]  
Thaler L.M., Blevins Jr. L.S., The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency, J Clin Endocrinol Metab, 83, pp. 2726-2729, (1998)
[7]  
Abdu T.A., Elhadd T.A., Neary R., Clayton R.N., Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease, J Clin Endocrinol Metab, 84, pp. 838-843, (1999)
[8]  
Anthonisen N.R., Manfreda J., Warren C.P., Hershfield E.S., Harding G.K., Nelson N.A., Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease, Ann Intern Med, 106, pp. 196-204, (1987)
[9]  
Arlt W., Rosenthal C., Hahner S., Allolio B., Quality of glucocorticoid replacement in adrenal insufficiency: Clinical assessment vs. timed serum cortisol measurements, Clin Endocrinol (Oxf), 64, pp. 384-389, (2006)
[10]  
Widmer I.E., Puder J.J., Konig C., Pargger H., Zerkowski H.R., Girard J., Muller B., Cortisol response in relation to the severity of stress and illness, J Clin Endocrinol Metab, 90, pp. 4579-4586, (2005)